Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
69
NEPH Quote, Financials, Valuation and Earnings
Last price:
$5.58
Seasonality move
:
-4.94%
Day range:
$5.54 - $5.97
52-week range:
$1.39 - $6.42
Dividend yield:
0%
P/E ratio:
40.91x
P/S ratio:
3.39x
P/B ratio:
6.00x
Volume:
28.4K
Avg. volume:
73.4K
1-year change:
248.77%
Market cap:
$60M
Revenue:
$14.2M
EPS (TTM):
$0.14
Analysts' Opinion
-
Consensus RatingNephros, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.50, Nephros, Inc. has an estimated upside of 15.04% from its current price of $5.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $5.65.
Fair Value
-
According to the consensus of 1 analyst, Nephros, Inc. has 15.04% upside to fair value with a price target of $6.50 per share.
NEPH vs. S&P 500
-
Over the past 5 trading days, Nephros, Inc. has overperformed the S&P 500 by 15.42% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nephros, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nephros, Inc. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Nephros, Inc. reported revenues of $4.8M.
Earnings Growth
-
Nephros, Inc. has grown year-over-year earnings for 12 quarters straight. In the most recent quarter Nephros, Inc. reported earnings per share of $0.03.
Enterprise value:
56M
EV / Invested capital:
5.02x
Price / LTM sales:
3.39x
EV / EBIT:
38.77x
EV / Revenue:
3.12x
PEG ratio (5yr expected):
--
EV / Free cash flow:
20.60x
Price / Operating cash flow:
22.35x
Enterprise value / EBITDA:
35.24x
Gross Profit (TTM):
$11.2M
Return On Assets:
12.58%
Net Income Margin (TTM):
8.26%
Return On Equity:
16.22%
Return On Invested Capital:
14.16%
Operating Margin:
6.59%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $13.5M | $13.5M | $17.9M | $3.5M | $4.8M | |
| Gross Profit | $7.6M | $8.1M | $11.2M | $2.1M | $2.9M | |
| Operating Income | -$1.6M | -$960K | $1.4M | $206K | $314K | |
| EBITDA | -$1.1M | -$808K | $1.6M | $240K | $348K | |
| Diluted EPS | -$0.18 | -$0.09 | $0.14 | $0.02 | $0.03 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $13.6M | $9.1M | $8.5M | $7.4M | $10.7M | |
| Total Assets | $17.8M | $11.3M | $10.9M | $10.4M | $13.2M | |
| Current Liabilities | $1.8M | $1.6M | $1.8M | $1.1M | $2.5M | |
| Total Liabilities | $2.5M | $1.8M | $2.3M | $2.2M | $3.2M | |
| Total Equity | $15.3M | $9.6M | $8.6M | $8.2M | $10M | |
| Total Debt | $1.3M | $344K | $469K | $1.2M | $774K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $869K | -$2M | $2.7M | -$623K | $99K | |
| Cash From Investing | -- | -$125K | -- | -- | -- | |
| Cash From Financing | -$187K | -$7K | -$5K | -- | -$2K | |
| Free Cash Flow | $869K | -$2.2M | $2.7M | -$623K | $99K | |
NEPH
Sector
Market Cap
$60M
$491.2M
Price % of 52-Week High
88.01%
78.6%
Dividend Yield
0%
0%
Shareholder Yield
0.17%
1.55%
1-Year Price Total Return
248.77%
--
Beta (5-Year)
1.483
0.553
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.42
200-day SMA
Buy
Level
$3.50
Bollinger Bands (100)
Buy
Level
3.79 - 5.25
Chaikin Money Flow
Sell
Level
-3M
20-day SMA
Buy
Level
$5.03
Relative Strength Index (RSI14)
Buy
Level
56.81
ADX Line
Buy
Level
15.79
Williams %R
Neutral
Level
-38.6974
50-day SMA
Buy
Level
$5.13
MACD (12, 26)
Buy
Level
0.14
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
2.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-12.4962)
Buy
CA Score
(Annual)
Level (1.0957)
Sell
Beneish M-Score
(Annual)
Level (-1.9918)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-11.7402)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Stock Forecast FAQ
In the current month, NEPH has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NEPH average analyst price target in the past 3 months is $6.50.
-
Where Will Nephros, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nephros, Inc. share price will rise to $6.50 per share over the next 12 months.
-
What Do Analysts Say About Nephros, Inc.?
Analysts are divided on their view about Nephros, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nephros, Inc. is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Nephros, Inc.'s Price Target?
The price target for Nephros, Inc. over the next 1-year time period is forecast to be $6.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NEPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nephros, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of NEPH?
You can purchase shares of Nephros, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nephros, Inc. shares.
-
What Is The Nephros, Inc. Share Price Today?
Nephros, Inc. was last trading at $5.58 per share. This represents the most recent stock quote for Nephros, Inc.. Yesterday, Nephros, Inc. closed at $5.65 per share.
-
How To Buy Nephros, Inc. Stock Online?
In order to purchase Nephros, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NEPH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NEPH
Sector
P/E ratio
40.91x
18.84x
PEG ratio
--
0.18x
P/B ratio
6.00x
1.66x
Price / LTM sales
3.39x
0.84x
Growth Metrics
NEPH
Sector
Revenue growth
35.42%
5.05%
Earnings growth
75.29%
5.99%
Revenue (5-year growth)
6.51%
4.28%
Earnings forecast
-$0.02
$0.39
Profitability
NEPH
Sector
Profitability FY 2024
$8.6M
$255.3M
Return on invested capital
14.16%
4.75%
Return on assets
12.58%
3.13%
Return on equity
16.22%
8.17%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Feb
5
Balance Sheet
NEPH
Sector
Total cash
$5.2M
$142.6M
Short term investments
--
$32.7M
Total assets
$11.2M
$1.4B
Long term debt
$774K
$55.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
